Welcome to the ALIFE2 Study homepage
In total there will be 399 inclusions, approximately 100 will be performed by the NL-team (including all international non-UK sites) and 300 will be done by the UK-team.
Total randomizations: 279/401
Total registrations NL-team : 128/128
Total randomizations NL-team: 115/128
Total registrations UK-team: 273/300
Total randomizations UK-team: 164/300Last update: 18 February 2020
Anticoagulants for living fetuses in women with recurrent miscarriage and inherited thrombophilia
Are you an (international) physician willing to participate in the ALIFE2 study? Please contact Eva HamulyŠk at email@example.com.
With more than 50 international centers contributing to the ALIFE2 study, we have reached the huge milestone of 400 registered women! A huge thank you to all the participating women and investigators, we are getting so close to having answer to this important research question!
Wonderful news: as of September 18, we have 250 randomizations in the ALIFE2 study!!
November 2018Medizinische Universitšt Innsbruck, Austria is now a participating center! We are approaching 300 registrations and 200 randomizations in the ALIFE2 trial!
May 2017CHU Sainte-Justine in Montreal, Canada has opened for recruitment!
First ALIFE2 randomization in University Medical Center Ljubljana!
The University Medical Center Ljubljana in Slovenia has opened for recruitment!
The University of Illinois at Chicago has opened for recruitment!
Warwick Medical School, the first UK-ALIFE2 team (NHS grant) site has opened for inclusion!!
The ALIFE2 protocol has been published in TRIALS! (link here)